Abbott Laboratories (BCBA:ABT)
Argentina
· Delayed Price · Currency is ARS 41,620
+1,120 (2.77%)
Last updated: Mar 9, 2026, 1:09 PM BRT
Abbott Laboratories Ratios and Metrics
Market cap in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 269,064,813 | 316,199,857 | 202,265,940 | 154,491,179 | 33,906,310 | 24,785,975 | Upgrade
|
| Market Cap Growth | 10.02% | 56.33% | 30.92% | 355.64% | 36.80% | 57.12% | Upgrade
|
| Enterprise Value | 277,315,658 | 324,258,030 | 209,988,130 | 161,658,371 | 35,125,277 | 25,702,082 | Upgrade
|
| Last Close Price | 40540.00 | 47634.40 | 33107.23 | 26089.27 | 9134.59 | 6878.14 | Upgrade
|
| PE Ratio | 28.52 | 33.52 | 14.64 | 33.52 | 27.72 | 34.28 | Upgrade
|
| PS Ratio | 4.18 | 4.92 | 4.68 | 4.76 | 4.39 | 5.60 | Upgrade
|
| PB Ratio | 3.51 | 4.13 | 4.10 | 4.92 | 5.19 | 6.70 | Upgrade
|
| P/TBV Ratio | 8.21 | 9.65 | 10.96 | 31.28 | 55.76 | - | Upgrade
|
| P/FCF Ratio | 25.07 | 29.46 | 30.89 | 37.77 | 24.53 | 27.91 | Upgrade
|
| P/OCF Ratio | 19.38 | 22.77 | 22.92 | 26.32 | 19.98 | 22.92 | Upgrade
|
| EV/Sales Ratio | 4.43 | 5.04 | 4.86 | 4.99 | 4.54 | 5.81 | Upgrade
|
| EV/EBITDA Ratio | 15.79 | 18.57 | 19.01 | 19.11 | 16.02 | 19.64 | Upgrade
|
| EV/EBIT Ratio | 22.00 | 25.05 | 27.17 | 27.69 | 21.76 | 27.19 | Upgrade
|
| EV/FCF Ratio | 25.84 | 30.21 | 32.07 | 39.52 | 25.41 | 28.94 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.32 | 0.41 | 0.49 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 1.14 | 1.14 | 1.38 | 1.48 | 1.41 | 1.47 | Upgrade
|
| Debt / FCF Ratio | 1.91 | 1.91 | 2.41 | 3.16 | 2.30 | 2.23 | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.10 | 0.15 | 0.22 | 0.21 | 0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.43 | 0.43 | 0.69 | 0.83 | 0.63 | 0.71 | Upgrade
|
| Net Debt / FCF Ratio | 0.70 | 0.70 | 1.16 | 1.72 | 1.00 | 1.04 | Upgrade
|
| Asset Turnover | 0.53 | 0.53 | 0.54 | 0.54 | 0.58 | 0.58 | Upgrade
|
| Inventory Turnover | 3.03 | 3.03 | 2.92 | 2.81 | 3.37 | 3.56 | Upgrade
|
| Quick Ratio | 1.02 | 1.02 | 1.05 | 1.00 | 1.06 | 1.28 | Upgrade
|
| Current Ratio | 1.58 | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | Upgrade
|
| Return on Equity (ROE) | 12.96% | 12.96% | 30.91% | 15.11% | 19.01% | 20.49% | Upgrade
|
| Return on Assets (ROA) | 6.63% | 6.63% | 6.06% | 6.11% | 7.61% | 7.79% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.01% | 12.14% | 14.59% | 13.45% | 16.96% | 17.46% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.70% | 12.70% | 11.10% | 12.20% | 15.50% | 14.80% | Upgrade
|
| Earnings Yield | 3.51% | 3.00% | 6.83% | 3.00% | 3.62% | 2.93% | Upgrade
|
| FCF Yield | 3.99% | 3.39% | 3.24% | 2.65% | 4.08% | 3.58% | Upgrade
|
| Dividend Yield | 1.23% | 7.31% | 6.98% | 6.45% | 3.72% | 2.72% | Upgrade
|
| Payout Ratio | 63.09% | 63.09% | 28.62% | 62.13% | 47.73% | 45.28% | Upgrade
|
| Buyback Yield / Dilution | -0.06% | -0.06% | 0.06% | 0.85% | 1.40% | -0.17% | Upgrade
|
| Total Shareholder Return | 1.18% | 7.26% | 7.03% | 7.30% | 5.12% | 2.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.